Company Announcements

Covid Corporate Financing Facility (CCFF) Update

Source: RNS
RNS Number : 2025L
Barratt Developments PLC
28 April 2020
 

 

 

28 April 2020

Barratt Developments PLC

Covid Corporate Financing Facility (CCFF) Update

Barratt Developments PLC (the 'Group'), Britain's largest housebuilder, is pleased to have received confirmation that it is eligible to access funding under the CCFF, should that be required.

As a business we continue to focus on taking the right actions and planning for the future so that we are well-placed to be able to continue to deliver the high quality homes the country needs when it is safe and appropriate to do so.

 

This announcement contains inside information. The person responsible for arranging for the release of this announcement on behalf of Barratt Developments PLC is Claire Adams (Head of Investor Relations).

 

Further information

For further information please contact:

Barratt Developments PLC

Jessica White, Chief Financial Officer                                                     01530 278 259

 

Analyst / investor enquiries

Claire Adams, Head of Investor Relations                                             01530 278 270

 

Media enquiries

Tim Collins, Head of Corporate Communications                                020 7299 4874

 

Brunswick

Jonathan Glass/ Rosie Oddy                                                                    020 7404 5959

 

This trading update contains certain forward-looking statements about the future outlook for the Group. Although the Directors believe that these statements are based upon reasonable assumptions, any such statements should be treated with caution as future outlook may be influenced by factors that could cause actual outcomes and results to be materially different.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPPUMCCUPUGWR